Miczid T 250mg/31.25mg Injection
Marketer
Biotanic Pharmaceuticals
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Miczid T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits bacterial proliferation, thus curbing infection spread. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; prematurely halting treatment can compromise its efficacy. Complete the full course even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects warrant immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) necessitate prompt medical help. Inform your physician of all current medications, particularly if you're pregnant, breastfeeding, or have pre-existing conditions. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are essential for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Miczid T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Miczid T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Miczid T 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Miczid T 250mg/31.25mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
How Miczid T 250mg/31.25mg Injection works:
Miczid T Injection (250mg/31.25mg) combines the antibiotic Ceftazidime with the beta-lactamase inhibitor Tazobactum. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance, thereby bolstering Ceftazidime's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Miczid T 250mg/31.25mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Miczid T 250mg/31.25mg Injection is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Miczid T 250mg/31.25mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, posing no known threat to the infant.
DrivingUNSAFE
The administration of Miczid T 250mg/31.25mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCAUTION
The injection Miczid T 250mg/31.25mg requires careful administration for individuals with impaired kidney function. Dosage modification may be necessary. A physician's advice is recommended.
LiverCAUTION
The administration of Miczid T 250mg/31.25mg Injection requires careful consideration in individuals exhibiting severe hepatic impairment. Dosage modification of Miczid T 250mg/31.25mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Miczid T 250mg/31.25mg Injection :
Omit a dose of Miczid T 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Miczid T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
3,018 People bought this recently